Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007795892> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2007795892 endingPage "66" @default.
- W2007795892 startingPage "61" @default.
- W2007795892 abstract "The objective of this study was to investigate the effect of renal impairment on the pharmacokinetics of the selective beta1-receptor antagonist talinolol.Pharmacokinetic data were obtained in 12 healthy volunteers, 12 patients with renal impairment and 8 patients with terminal renal insufficiency after the oral administration of 100 mg talinolol and under steady state conditions (100 mg talinolol daily). Concentrations of talinolol in plasma, urine and dialysate during hemodialysis were measured with a validated HPLC-method.Talinolol is absorbed quite rapidly from the gastrointestinal tract (tmax 2.5-4 h). Steady state conditions were reached within 3-4 days depending on renal function. The calculated mean elimination half-life (t(1/2z)) in healthy volunteers (11 male, 1 female) was about 12 h. After an oral dose of 100 mg, about 55% of the bioavailable talinolol is eliminated unchanged in the urine. This fraction is reduced to 25% in patients with moderate to severe renal failure. A strong correlation was found between the renal elimination of talinolol and creatinine clearance. In patients with renal failure, the delayed elimination leads to an increase in t(1/2z) and to a decrease in the apparent total body clearance. Steady state trough levels (c(min)ss) in these patients are about 2.2-fold higher than in volunteers. The hemodialysability of talinolol was low.The disposition of talinolol shows a strong dependence on the renal function. On the basis of the kinetic data for talinolol, dose reductions of 30-50% are recommended in subjects with moderate to severe renal impairment." @default.
- W2007795892 created "2016-06-24" @default.
- W2007795892 creator A5008504945 @default.
- W2007795892 creator A5019800434 @default.
- W2007795892 creator A5032340718 @default.
- W2007795892 creator A5034551071 @default.
- W2007795892 creator A5057924098 @default.
- W2007795892 creator A5090550892 @default.
- W2007795892 creator A5090910657 @default.
- W2007795892 date "2001-02-01" @default.
- W2007795892 modified "2023-09-27" @default.
- W2007795892 title "Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers" @default.
- W2007795892 doi "https://doi.org/10.5414/cpp39061" @default.
- W2007795892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11270803" @default.
- W2007795892 hasPublicationYear "2001" @default.
- W2007795892 type Work @default.
- W2007795892 sameAs 2007795892 @default.
- W2007795892 citedByCount "8" @default.
- W2007795892 countsByYear W20077958922015 @default.
- W2007795892 countsByYear W20077958922017 @default.
- W2007795892 countsByYear W20077958922021 @default.
- W2007795892 crossrefType "journal-article" @default.
- W2007795892 hasAuthorship W2007795892A5008504945 @default.
- W2007795892 hasAuthorship W2007795892A5019800434 @default.
- W2007795892 hasAuthorship W2007795892A5032340718 @default.
- W2007795892 hasAuthorship W2007795892A5034551071 @default.
- W2007795892 hasAuthorship W2007795892A5057924098 @default.
- W2007795892 hasAuthorship W2007795892A5090550892 @default.
- W2007795892 hasAuthorship W2007795892A5090910657 @default.
- W2007795892 hasConcept C112705442 @default.
- W2007795892 hasConcept C126322002 @default.
- W2007795892 hasConcept C126894567 @default.
- W2007795892 hasConcept C159641895 @default.
- W2007795892 hasConcept C2777056448 @default.
- W2007795892 hasConcept C2780026642 @default.
- W2007795892 hasConcept C71924100 @default.
- W2007795892 hasConcept C98274493 @default.
- W2007795892 hasConceptScore W2007795892C112705442 @default.
- W2007795892 hasConceptScore W2007795892C126322002 @default.
- W2007795892 hasConceptScore W2007795892C126894567 @default.
- W2007795892 hasConceptScore W2007795892C159641895 @default.
- W2007795892 hasConceptScore W2007795892C2777056448 @default.
- W2007795892 hasConceptScore W2007795892C2780026642 @default.
- W2007795892 hasConceptScore W2007795892C71924100 @default.
- W2007795892 hasConceptScore W2007795892C98274493 @default.
- W2007795892 hasIssue "02" @default.
- W2007795892 hasLocation W20077958921 @default.
- W2007795892 hasLocation W20077958922 @default.
- W2007795892 hasOpenAccess W2007795892 @default.
- W2007795892 hasPrimaryLocation W20077958921 @default.
- W2007795892 hasRelatedWork W1573667742 @default.
- W2007795892 hasRelatedWork W1982777678 @default.
- W2007795892 hasRelatedWork W2001333918 @default.
- W2007795892 hasRelatedWork W2006342447 @default.
- W2007795892 hasRelatedWork W2065186562 @default.
- W2007795892 hasRelatedWork W2145462538 @default.
- W2007795892 hasRelatedWork W2317627837 @default.
- W2007795892 hasRelatedWork W2400700397 @default.
- W2007795892 hasRelatedWork W2414263157 @default.
- W2007795892 hasRelatedWork W2431352314 @default.
- W2007795892 hasVolume "39" @default.
- W2007795892 isParatext "false" @default.
- W2007795892 isRetracted "false" @default.
- W2007795892 magId "2007795892" @default.
- W2007795892 workType "article" @default.